Brand names: Sorafenib Tosylate
3 interactions on record
Neomycin The concomitant use of sorafenib tablets with neomycin decreased the mean AUC of sorafenib, which may decrease the antitumor activity. Avoid concomitant use of sorafenib tablets with neomycin.
Source: FDA drug label - sorafenib
Re gorafenib Clinical Impact: Regorafenib increased rosuvastatin exposure and may increase the risk of myopathy. I ntervention: In patients taking regorafenib, do not exceed a dose of EZALLOR SPRINKLE 10 mg once daily .
Source: FDA drug label - rosuvastatin
Re gorafenib Clinical Impact: Regorafenib increased rosuvastatin exposure and may increase the risk of myopathy. I ntervention: In patients taking regorafenib, do not exceed a dose of rosuvastatin 10 mg once daily .
Source: FDA drug label - rosuvastatin calcium